Intuitive Surgical (ISRG) Share-based Compensation (2009 - 2026)
Intuitive Surgical (ISRG) posted Share-based Compensation of $67.1 million for Q2 2026, down 80.95% on a QoQ basis from $352.3 million in Q1 2026, and up 314.2% year-over-year from $16.2 million in Q2 2025.
Analysis
Intuitive Surgical (ISRG) Share-based Compensation (2009 - 2026) Analysis & Trends
Intuitive Surgical has reported Share-based Compensation for 18 years, with the latest figure at $67.1 million in Q2 2026.
- On a quarterly basis, Share-based Compensation rose 314.2% year-over-year to $67.1 million in Q2 2026; TTM through Jun 2026 was $821.3 million, a 11.56% increase from a year earlier, with the FY2025 full-year figure at $788.2 million, up 16.46% from the prior year.
- Share-based Compensation was $67.1 million for Q2 2026 at Intuitive Surgical, down from $352.3 million in the prior quarter.
- The five-year high for Share-based Compensation was $370.1 million in Q1 2025, with the low at $16.2 million in Q2 2025.
- Average Share-based Compensation over 5 years is $166.1 million, with a median of $153.2 million recorded in 2023.
- The sharpest annual moves came in 2025 and 2026: Share-based Compensation slumped 83.85% in 2025, then surged 314.2% in 2026.
- Over 5 years, Share-based Compensation stood at $127.6 million in 2022, then rose by 17.87% to $150.4 million in 2023, then increased by 17.69% to $177.0 million in 2024, then advanced by 14.86% to $203.3 million in 2025, then slumped by 66.99% to $67.1 million in 2026.
- The last three Share-based Compensation figures came in at $67.1 million (Q2 2026), $352.3 million (Q1 2026), and $203.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Zimmer Biomet Holdings | 17.73 Bn | 17.32 Bn | 1.54 Bn | 23.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67.10 Mn |
| Mar 31, 2026 | 352.30 Mn |
| Dec 31, 2025 | 203.30 Mn |
| Sep 30, 2025 | 198.60 Mn |
| Jun 30, 2025 | 16.20 Mn |
| Mar 31, 2025 | 370.10 Mn |
| Dec 31, 2024 | 177.00 Mn |
| Sep 30, 2024 | 172.90 Mn |
| Jun 30, 2024 | 100.30 Mn |
| Mar 31, 2024 | 226.60 Mn |
| Dec 31, 2023 | 150.40 Mn |
| Sep 30, 2023 | 156.10 Mn |
| Jun 30, 2023 | 146.50 Mn |
| Mar 31, 2023 | 139.80 Mn |
| Dec 31, 2022 | 127.60 Mn |
| Sep 30, 2022 | 138.10 Mn |
| Jun 30, 2022 | 75.30 Mn |
| Mar 31, 2022 | 172.20 Mn |
| Dec 31, 2021 | 117.80 Mn |
| Sep 30, 2021 | 120.10 Mn |